Genetic breast cancer tests create opportunities, confusion

The past decade has witnessed a rapid expansion of genetic tests, including new instruments to inform patients who have been diagnosed with breast cancer about the risk of recurrence and to guide their treatment.

Related Keywords

New York ,United States ,Georgia ,Memorial Sloan Kettering Cancer Center ,Sterling Heights ,Michigan ,American ,Mark Robson ,Steven Katz ,Jen Carbary ,Sloan Kettering ,Tuya Pal ,Allison Kurian ,Eric Manahan ,Vanderbilt Ingram Cancer Center ,Kaiser Family Foundation ,American Society Of Breast Surgeons ,University Of Michigan ,Kaiser Health News ,Stanford University ,National Comprehensive Cancer Network ,Myriad Genetics ,Ashkenazi Jewish ,American Society ,Breast Surgeons ,Memorial Sloan Kettering ,Policy Analysis ,